Completed NA INTERVENTIONAL 1-arm NCT02703064

Furocyst - Poly Cystic Ovary Syndrome Study

To Study the Efficacy and Safety of Furocyst in Poly Cystic Ovary Syndrome Patients (PCOS)

Sponsor: Chemical Resources

Conditions PCOS

Interventions Furocyst

Updated 7 times since 2017 Last updated: Sep 14, 2017 Started: Mar 26, 2015 Primary completion: Jul 31, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on PCOS, this trial is completed. The trial is conducted by Chemical Resources and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Oct 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Oct 2017 [monthly]

Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chemical Resources

Data source: Chemical Resources

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lucknow, India